Logo image of QS

QUANTUMSCAPE CORP (QS) Stock Fundamental Analysis

NYSE:QS - New York Stock Exchange, Inc. - US74767V1098 - Common Stock - Currency: USD

5.18  -0.15 (-2.81%)

After market: 5.165 -0.01 (-0.29%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to QS. QS was compared to 83 industry peers in the Automobile Components industry. QS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. QS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year QS has reported negative net income.
QS had a negative operating cash flow in the past year.
In the past 5 years QS always reported negative net income.
QS had a negative operating cash flow in each of the past 5 years.
QS Yearly Net Income VS EBIT VS OCF VS FCFQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -500M -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -37.47%, QS is doing worse than 92.77% of the companies in the same industry.
With a Return On Equity value of -42.91%, QS is not doing good in the industry: 87.95% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -37.47%
ROE -42.91%
ROIC N/A
ROA(3y)-20.08%
ROA(5y)N/A
ROE(3y)-22.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QS Yearly ROA, ROE, ROICQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for QS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QS Yearly Profit, Operating, Gross MarginsQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023

5

2. Health

2.1 Basic Checks

QS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QS Yearly Shares OutstandingQS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M 400M
QS Yearly Total Debt VS Total AssetsQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

A Debt/Equity ratio of 0.03 indicates that QS is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.03, QS belongs to the best of the industry, outperforming 91.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
QS Yearly LT Debt VS Equity VS FCFQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

QS has a Current Ratio of 14.07. This indicates that QS is financially healthy and has no problem in meeting its short term obligations.
QS has a better Current ratio (14.07) than 100.00% of its industry peers.
QS has a Quick Ratio of 14.07. This indicates that QS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 14.07, QS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.07
Quick Ratio 14.07
QS Yearly Current Assets VS Current LiabilitesQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500M 1B

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.08% over the past year.
EPS 1Y (TTM)2.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

QS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.31% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y10.31%
EPS Next 2Y7.82%
EPS Next 3Y8.49%
EPS Next 5Y15.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QS Yearly Revenue VS EstimatesQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
QS Yearly EPS VS EstimatesQS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QS Price Earnings VS Forward Price EarningsQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QS Per share dataQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.82%
EPS Next 3Y8.49%

0

5. Dividend

5.1 Amount

QS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

QUANTUMSCAPE CORP

NYSE:QS (2/21/2025, 8:04:01 PM)

After market: 5.165 -0.01 (-0.29%)

5.18

-0.15 (-2.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-22 2025-04-22/amc
Inst Owners29.99%
Inst Owner Change11.68%
Ins Owners3.11%
Ins Owner Change-0.84%
Market Cap2.65B
Analysts49.41
Price Target6.03 (16.41%)
Short Float %17.48%
Short Ratio3.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.1%
Min EPS beat(2)-7.87%
Max EPS beat(2)-6.33%
EPS beat(4)1
Avg EPS beat(4)1.84%
Min EPS beat(4)-12.74%
Max EPS beat(4)34.32%
EPS beat(8)2
Avg EPS beat(8)-3.24%
EPS beat(12)2
Avg EPS beat(12)-12.69%
EPS beat(16)2
Avg EPS beat(16)-509.26%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.71%
EPS NY rev (1m)0%
EPS NY rev (3m)4.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.39
P/tB 2.39
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpSN/A
BVpS2.17
TBVpS2.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.47%
ROE -42.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-20.08%
ROA(5y)N/A
ROE(3y)-22.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset TurnoverN/A
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 114.53%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.07
Quick Ratio 14.07
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)622.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.35%
EPS Next Y10.31%
EPS Next 2Y7.82%
EPS Next 3Y8.49%
EPS Next 5Y15.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.98%
EBIT Next 3Y7.51%
EBIT Next 5Y11.68%
FCF growth 1Y7.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.88%
OCF growth 3YN/A
OCF growth 5YN/A